Targeting ARID1A-mutated gastric cancer cells with synthetic lethal approaches

被引：0
|
作者：
Fang, Menghan
Lin, Youfen
Xue, Chaorong
Sheng, Kaiqin
Guo, Zegeng
Han, Yuting
Lin, Hanbin
Wu, Yuecheng
Howell, Stephen B.
Lin, Xu
Lin, Xinjian
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3221
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3221
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib
    Miller, Rowan E.
    Brough, Rachel
    Bajrami, Ilirjana
    Williamson, Chris T.
    McDade, Simon
    Campbell, James
    Kigozi, Asha
    Rafiq, Rumana
    Pemberton, Helen
    Natrajan, Rachel
    Joel, Josephine
    Astley, Holly
    Mahoney, Claire
    Moore, Jonathan D.
    Torrance, Chris
    Gordan, John D.
    Webber, James T.
    Levin, Rebecca S.
    Shokat, Kevan M.
    Bandyopadhyay, Sourav
    Lord, Christopher J.
    Ashworth, Alan
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (07) : 1472 - 1484
  • [32] Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial Carcinoma
    Gupta, Sumati
    Albertson, Daniel J.
    Parnell, Timothy J.
    Butterfield, Andrew
    Weston, Alexis
    Pappas, Lisa M.
    Dalley, Brian
    O'Shea, John M.
    Lowrance, William T.
    Cairns, Bradley R.
    Schiffman, Joshua D.
    Sharma, Sunil
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (01) : 185 - 195
  • [33] Synthetic lethal approaches to breast cancer therapy
    Farah L. Rehman
    Christopher J. Lord
    Alan Ashworth
    Nature Reviews Clinical Oncology, 2010, 7 : 718 - 724
  • [34] Synthetic lethal approaches to breast cancer therapy
    Rehman, Farah L.
    Lord, Christopher J.
    Ashworth, Alan
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (12) : 718 - 724
  • [35] EGLN1 is a synthetic lethal target in ARID1A-mutant ovarian cancer
    Briggs, Kimberly J.
    Min, Chengyin
    Zhang, Hongxiang
    Huang, Alan
    CANCER RESEARCH, 2018, 78 (13)
  • [36] Targeting BRCA1-mutated cancer cells with elesclomol
    Kammire, Maria
    Fannin, Emily
    Ford, James M.
    Alli, Elizabeth
    CANCER RESEARCH, 2018, 78 (13)
  • [37] miR-7641 depletion suppresses proliferation of gastric cancer cells by targeting ARID1A
    Yang Yan
    Yin Zong Xiu
    Wang Zhao Yang
    Tian Shu Bo
    Wang Hong Chang
    Zhang Fang Xu
    Li Le Ping
    Zheng Chunning
    Kong Shuai
    ANTI-CANCER DRUGS, 2020, 31 (04) : 368 - 376
  • [38] Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells
    Yarui Ma
    Qing Zhu
    Xiaobing Wang
    Mei Liu
    Qichen Chen
    Liming Jiang
    Yihebali Chi
    Yi-Xin Zeng
    Hong Zhao
    Yuchen Jiao
    Cell Research, 2022, 32 : 596 - 599
  • [39] Synthetic lethal screening identifies DHODH as a target for MEN1-mutated tumor cells
    Ma, Yarui
    Zhu, Qing
    Wang, Xiaobing
    Liu, Mei
    Chen, Qichen
    Jiang, Liming
    Chi, Yihebali
    Zeng, Yi-Xin
    Zhao, Hong
    Jiao, Yuchen
    CELL RESEARCH, 2022, 32 (06) : 596 - 599
  • [40] Synthetic Lethal Metabolic Targeting of Androgen-Deprived Prostate Cancer Cells with Metformin
    Yang, Bing
    Damodaran, Shivashankar
    Khemees, Tariq A.
    Filon, Mikolaj J.
    Schultz, Adam
    Gawdzik, Joseph
    Etheridge, Tyler
    Malin, Dmitry
    Richards, Kyle A.
    Cryns, Vincent L.
    Jarrard, David F.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (11) : 2278 - 2287
12345